Peer Comparison
| Company | Market Price | MCAP(Cr) | P/B | P/E | EPS | ROE |
|---|---|---|---|---|---|---|
| GLAXO | 1292.7(0.8%) | 21,714 | 13.3 | 52.0 | 45.2 | 29.8 |
| IPCALAB | 785.5(0.5%) | 19,810 | 3.3 | 36.5 | 20.4 | 17.9 |
| BIOCON | 198(-1.9%) | 24,228 | 2.7 | 22.5 | 9.9 | 12.5 |
| GLAND | 1201.85(3.6%) | 19,167 | 2.4 | 19.5 | 24.8 | 18.6 |
| LAURUSLABS | 305.25(0.9%) | 16,289 | 4.1 | 18.5 | 39.8 | 45.2 |
| PFIZER | 3516.75(-0.5%) | 16,163 | 5.3 | 26.1 | 54.2 | 38.7 |
| PEL | 671.95(2.4%) | 15,654 | 0.7 | 4.9 | 7.7 | 3.9 |
| AUROPHARMA | 474(-0.1%) | 27,788 | 1.6 | 20.0 | 12.8 | 11.5 |
| AJANTPHARM | 1197.95(1.2%) | 15,158 | 4.2 | 26.3 | 29.4 | 22.8 |
| JBCHEPHARM | 1957.1(0.1%) | 15,125 | 6.4 | 39.5 | 25.5 | 19.9 |
| LUPIN | 649.1(0.4%) | 29,401 | 1.6 | 108.8 | -7.1 | -11.8 |
| SANOFI | 5725.95(0.2%) | 13,164 | 10.3 | 21.2 | 59.8 | 40.8 |
| GLENMARK | 440.95(-0.9%) | 12,556 | 0.7 | 8.1 | 15.3 | 20.8 |
| SUVENPHAR | 469.3(-0.2%) | 12,013 | 7.4 | 22.8 | 44.5 | 37.8 |
| NATCOPHARM | 537.5(-0.3%) | 9,840 | 2.2 | 30.6 | 4.9 | 4.1 |
